Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VICR✓SelectedUSD · VICRGSK vs VICR performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs VICR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,596.0%
VICR return
+9,268.1%
Excess return
-7,672.1%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioVICRExcessAlpha
1D-1.3%+0.4%-1.8%-1.4%
7D-3.1%-13.4%+10.3%-2.2%
30D-0.9%-23.6%+22.8%+0.4%
3M-4.2%-39.9%+35.8%-2.1%
6M-1.6%-41.5%+39.9%-0.5%
YTD+2.6%+32.8%-30.2%-3.8%
1Y+6.2%+72.0%-65.8%-2.3%
3Y+55.0%+270.9%-216.0%+29.5%
5Y+42.8%-10.2%+53.0%+27.7%
10Y+102.1%+932.6%-830.4%+38.4%
All+1,596.0%+9,268.1%-7,672.1%+604.1%

Cumulative growth

Daily Returns

Daily percentage return beside VICR.

Daily Out/Under-Performance

Portfolio return minus VICR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VICR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded VICR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling